Markus is an entrepreneurial investor specializing in growth stage investment. His portfolio includes companies serving the Pharmaceutical, Medical Device, Software / High Technology, and Agriculture industries.
Markus has also founded companies such as the Swiss pharmaceutical company TIMA, and in 1998, he purchased the Domaine Prive winery. The winery was modernised and transformed it into one of the leading newcomer wine estates in Europe.
His investments are geographically diversified, with portfolio companies headquartered in the US, Japan, Thailand, Germany, France, UK, and Scandinavia.
Upon exit, his portfolio companies have produced an average return on investment of 6.8 times.